Moody Aldrich Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,049	Closed	-$616K	–	202
2024 Q1	$616K	Hold	7,049	–	–	0.1%	132
2023 Q4	$680K	Buy	7,049 +1,392	+25%	+$134K	0.12%	123
2023 Q3	$501K	Buy	+5,657	New	+$501K	0.09%	128